Physician profile
Melissa Heidi
NPI 1245422161
$1,256.38
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $46.51 · 2021: $118 · 2022: $498 · 2023: $55.91 · 2024: $45.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $375.81 | 2019-2023 | |
| Gynesonics, INC. | $314.51 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $134.29 | 2019-2022 | |
| Minerva Surgical, INC | $101.54 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $49.24 | 2019 | |
| Novo Nordisk INC | $42.86 | 2023 | Wegovy |
| Exeltis, USA INC. | $35.89 | 2019-2022 | |
| Roche Diagnostics Corporation | $32.79 | 2019 | |
| Lupin INC. | $31.25 | 2019-2020 | |
| Allergan, INC. | $22.64 | 2019 | |
| Astellas Pharma US INC | $17.53 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.39 | 2020 | |
| Sumitomo Pharma America, INC. | $16.12 | 2024 | Myfembree |
| Pfizer INC. | $15.70 | 2022 | |
| Vertical Pharmaceuticals, LLC | $13.28 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $13.00 | 2020 | |
| Amgen INC. | $11.52 | 2022 | |
| Merck Sharp & Dohme LLC | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Heidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.